Intellectual Property Throughout the Drug Development Lifecycle: Opportunities and Challenges
July 17, 2012
Washington, DC
Food and Drug Law Institute
Finnegan partner Rich Racine will participate in the panel discussion “The Role of IP During Drug Discovery and Pre-Clinical Development” at the Food and Drug Law Institute’s IP drug discovery lifecycle forum. The program will take place at the offices of Venable LLP in Washington, DC. For more information, or to register, please see FDLI’s website.
